Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03763708
Other study ID # MDT18036
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date December 12, 2018
Est. completion date January 2029

Study information

Verified date June 2023
Source MedtronicNeuro
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To characterize the effects of stimulation parameters on pain relief and other cohort specific outcomes.


Description:

This post market study will measure the following: - Numeric Pain Rating Scale - Satisfaction and Stimulation Assessment - Stimulation feedback - Stimulation parameters - Anatomical locations of active contacts - Stimulation thresholds - Location of paresthesia - Oswestry Disability Index - European Quality of Life 5-Dimensions - To characterize non-invasive health monitoring data


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 360
Est. completion date January 2029
Est. primary completion date January 2029
Accepts healthy volunteers No
Gender All
Age group 22 Years and older
Eligibility Inclusion Criteria: 1. 22 years of age or older 2. Implanted with a Medtronic rechargeable neurostimulation system, for a labeled indication, for at least 1 month and expected longevity of neurostimulator is at least 5 months 3. Willing and able to provide signed and dated informed consent 4. Capable of comprehending and consenting in English 5. Willing and able to comply with all study procedures, including diary completion, and visits 6. Able to differentiate between pain associated with the indication for SCS implant and other types of pain Exclusion Criteria: 1. Implanted with neurostimulation system for an off-label indication 2. Currently enrolled or planning to enroll in an interventional clinical study that could potentially confound the study results 3. If female, pregnant or is of child-bearing potential and unwilling to use a medically acceptable form of birth control during the study 4. Has untreated major psychiatric comorbidity 5. Has a non-rechargeable neurostimulator where the battery longevity is not able to be estimated with the battery longevity calculator

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Spinal Cord Stimulation
Programming

Locations

Country Name City State
United States Regional Brain and Spine Cape Girardeau Missouri
United States Goodman Campbell Brain and Spine Carmel Indiana
United States Twin Cities Pain Clinic Edina Minnesota
United States Carolinas Research Institute Huntersville North Carolina
United States Center for Interventional Pain and Spine Lancaster Pennsylvania
United States West Virginia University Morgantown West Virginia
United States Center for Pain and Supportive Care Phoenix Arizona
United States Pain Diagnostics and Interventional Care Sewickley Pennsylvania
United States Drez One Somerset Kentucky
United States Northwest Pain Care Spokane Washington

Sponsors (1)

Lead Sponsor Collaborator
MedtronicNeuro

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Numeric pain rating scale To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded in clinic or once a day on a multi-day diary, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score from the diary prior to the scheduled visit will be used for analysis. Up to 16 months
See also
  Status Clinical Trial Phase
Approved for marketing NCT00866164 - Prometra's Utilization in Mitigating Pain II N/A